← Back to Search

Behavioural Intervention

Mediterranean Diet (MD) for Autoimmune Hepatitis

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Established autoimmune hepatitis (AIH) confirmed according to simplified criteria (>6) or historical confirmatory liver biopsy with inflammation consistent with AIH
Current age: 18 to 80 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial will compare the effects of two different diets, Western Diet and Mediterranean Diet, on quality-of-life parameters in patients with AIH. Participants will try both diets in two separate phases, and will

Who is the study for?
This trial is for individuals with autoimmune hepatitis who experience fatigue. Participants will be part of a study comparing the effects of two diets on their quality of life.Check my eligibility
What is being tested?
The study tests how a Mediterranean Diet (MD) versus a Western Diet (WD) affects patients' fatigue levels. It's a cross-over pilot study, meaning participants will try both diets in different phases to see which one works better.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include digestive adjustments or food sensitivities as the body adapts to new eating patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with autoimmune hepatitis.
Select...
I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in clinical fatigue via Promis 29
Secondary outcome measures
Change in IgG value
Change in alanine transaminase (ALT) value
Change in overall health related quality of life via Promis 29
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Mediterranean Diet (MD)Active Control1 Intervention
The Mediterranean Diet (MD) includes similar food patterns to those described in the Healthy Mediterranean-Style Dietary Pattern in the Dietary Guidelines for Americans, 2020-2025. The daily caloric needs of participants will be calculated to ensure weight stability. For a daily 2,000 kcal diet, participants will consume 2.5 cup equivalents of vegetables, 2.5 cup equivalents of fruits, 3 ounce equivalents of whole grains, 2 cup equivalents of dairy, 6 ounces equivalent of protein foods (with 32% from seafood, and 11% from nuts, seeds and soy products), and 27 grams of canola or olive oil, per day. No more than 12% of calories per day will come from discretionary foods (I.e., added sugar, saturated fat).
Group II: Western Diet (WD)Active Control1 Intervention
The Western Diet (WD) includes similar food patterns to those described in the Data Tables of What We Eat in America, NHANES (13) . We will match intake according to gender and age group in years (I.e., 20-29; 30-39; 40-49; 50-59; 60-69; 70 and over). On average, participants will consume 1.6 cup equivalent of vegetables, 0.9 cup equivalents of fruits, 0.8 ounce equivalents of whole grains,1.4 cup equivalents of dairy, 6.3 ounces equivalent of protein foods (with 10% from seafood, and 14% from nuts, seeds and soy products). The diet will contain 12% of calories per day from saturated fat, and 12.7% of calories from added sugars.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,714 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would it be possible for me to participate in this medical study?

"Candidates eligible for this study must have autoimmune hepatitis and fall within the age range of 18 to 80 years. The trial aims to recruit a total of 48 participants."

Answered by AI

Are there still opportunities for potential participants to enroll in this clinical trial?

"According to information available on clinicaltrials.gov, this trial is currently in the recruitment phase. The study was initially listed on 10/23/2023 and most recently updated on 2/1/2024."

Answered by AI
~32 spots leftby Dec 2027